MARIA GARDE: Open Payments
NPI 1700886165 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 25 payments from 10 companies in 2025. Trend: 2023 $312 · 2024 $486 · 2025 $495
Food & beverage: $495
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 9 | $152 |
| Novo Nordisk Inc | 4 | $79 |
| Exact Sciences Corporation | 3 | $69 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| SANOFI-AVENTIS U.S. LLC | 1 | $37 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Abbott Laboratories | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: MOUNJARO, Cologuard Collection Kit, Wegovy, TZIELD, Kerendia, FARXIGA, FREESTYLE LIBRE 3, EVKEEZA.
Industry payments across MD — which companies pay providers there.
